Someone tried very hard to convince me that aspartame, an artificial sweetener, is bad for you. The only paper that came close was this one which concludes that there is a significant risk of rats developing leukemia if they consume 2000ppm of aspartame daily.
However, if you do the math, the sheer amount of aspartame needed is incredible.
To show my point, I calculated how many cans of Coke Zero you’d need to consume per day in order to develop leukemia from the aspartame content.
9834.5 cans of Coke Zero.
If you drank 9834.5 cans of Coke Zero a day, you would be more likely to die of …well, anything, before the aspartame affected you.
How I calculate it:
The chance of developing a malignant tumour is significant at a level of 2000ppm in rats.
2000ppm = 2000mg per kg.
To convert to human dosage, you multiply the value by the NOAEL value for the drug and animal. That’s 4000.
So in humans, a dosage of 8000mg (8g) per kg of body weight is dangerous.
I weigh 71.3kg, so I shouldn’t consume more than 570400mg (570.4g) of aspartame a day.
There are 58mg of Aspartame in 1 can of Coke Zero.
570.4g/58mg is 9834.5 cans of Coke Zero.
I was working on my book last night, extracting charts from the World Health Organisation’s databases to demonstrate improvements since 2000, and noticed something interesting.
This is a chart showing the decrease in deaths in Ireland, in people aged 30-49, for diseases strongly related to smoking:
Basically, since 2000, deaths from lung-related diseases have halved.
Why is that?
I believe it’s because in 2004, Ireland introduced a total ban on smoking in work-places. That includes restaurants and pubs.
Compare that to China, where there isn’t a ban on smoking, and where it’s actually considered polite to offer cigarettes to your visitors:
Or Russia, where smoking in public places was banned only in 2013:
The same pattern is visible in most countries. Countries that introduced a smoking ban saw a dramatic decrease in deaths, while those that don’t introduce a ban see their citizens continue to die of lung-related diseases.
A clinical trial run by Cancer Research UK has shown that by combining androgen-deprived therapy (ADT) with the drug abiraterone in the treatment of prostate cancer sufferers, they reduced the chance of dying from prostate cancer in the next three years by 37%.
Prostate cancer currently kills about 11,000 people per year in the UK. In 2012, an estimated 310,000 people died from it worldwide.
According to the paper, the chance of dying within three years using just ADT, which is the standard treatment at the moment, was 76%. When combined with abiraterone, this increased dramatically to 83%. Out of the 1917 people that were recruited for the trial, nearly 80 of them were alive at the end of the trial that would have died if they had just been on ADT.